Innovent, Lilly’s mazdutide trumps Novo’s semaglutide in head-to-head diabetes, weight loss study
Innovent’s Eli Lilly-partnered mazdutide, a GLP-1/glucagon (GCG) dual receptor agonist, displayed broader effects on patients’ blood glucose levels and weight loss than Novo’s leading GLP-1 semaglutide in a head-to-head trial.
Why Ozempic and Wegovy Don’t Cause Weight Loss for Everyone
Scientists look to genetics to explain why GLP-1 drugs work for some people but not for others
How does front end innovation work at Givaudan? In conversation with Alexandre Bastos
What is “front-end innovation” and how is it structured at global flavors and fragrances giant Givaudan? “Our teams can [assess] one [startup] here and another there, but the 1,000 companies we see every year, it’s more coming from accelerators, VC investors and other scouters that are out there looking for our needs,” says Alexandre Bastos, […]
Popular Weight-Loss Drug May Guard Against Cataracts
People with overweight or obesity who use GLP-1 receptor agonists may have a lower risk of developing cataracts than those who use other drugs for weight loss or receive no treatment. Medscape Medical News
MOH to introduce new diabetes and obesity drug for vulnerable groups under Budget 2026
KUALA LUMPUR, Oct 27 — The Ministry of Health (MOH) will roll out a new generation drug to support diabetes and obesity patients among vulnerable groups under Budget 2026, as part of efforts to enhance treatment for non-communicable diseases (NCDs). Minister Datuk Seri Dzulkefly Ahmad said the move comes after continuous evaluations of the MOH […]
Development and validation of an LC-MS/MS method for Tirzepatide, a dual GIP/GLP-1 receptor agonist, in rat plasma for application to a pharmacokinetic study
Publication date: Available online 26 October 2025 Source: Journal of Chromatography B Author(s): Hae-In Choi, Hyeon-Cheol Jeong, Jong-Woo Jeong, Jaeyoung Lee, Da Hae Kim, Kyong-Cheol Ko, Yoon-Jee Chae, Kyeong-Ryoon Lee
Inside Sherwood: Covering healthcare, GLP-1s and the stories that matter to retail investors
How a disruptive media outlet thinks about pitches. Amanda Coffee is CEO of Coffee Communications and ex-Under Armour, PayPal and eBay. Sherwood is one of the newest players in business journalism, operating as the editorially independent news arm of Robinhood. With a mission to deliver finance and business news tailored to a retail investor audience, Sherwood […]
Tirzepatide-Hormone Therapy Combo Tied to Weight Loss in Postmenopausal Women
(MedPage Today) — ORLANDO — Postmenopausal women using hormone therapy (HT) saw significantly greater weight loss while taking the dual GIP/GLP-1 receptor agonist tirzepatide than their counterparts not using HT, according to a retrospective…
Weight-loss drugs like Ozempic may also curb drug and alcohol addiction
GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, and nicotine use. Though more research is needed, scientists believe these drugs could open a powerful new front in addiction therapy.
Popular weight-loss drugs could take the edge off your alcohol buzz, study finds
Popular drugs credited with shrinking waistlines and controlling blood sugar may also take the edge off alcohol’s buzz, according to a new study. Researchers at Virginia Tech’s Fralin Biomedical Research Institute analyzed how 20 adults with obesity — half of whom had been taking GLP-1 receptor agonists for at least four weeks — reacted to […]